| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42000535 | EBV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
| TVIS30079906 | HIV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
| TVIS30083071 | HIV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA1H |
|---|---|
| DrugBank ID | DB00661 |
| Drug Name | Verapamil |
| Target ID | BE0000864 |
| UniProt ID | O95180 |
| Regulation Type | inhibitor |
| PubMed IDs | 18974361 |
| Citations | Perez-Reyes E, Van Deusen AL, Vitko I: Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther. 2009 Feb;328(2):621-7. doi: 10.1124/jpet.108.145672. Epub 2008 Oct 30. |
| Groups | Approved |
| Direct Classification | Phenylbutylamines |
| SMILES | COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1 |
| Pathways | Verapamil Action Pathway |
| PharmGKB | PA451868 |
| ChEMBL | CHEMBL6966 |
